BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6031447)

  • 21. [Results of the use of the Leningrad-4 live measles vaccine during increasing measles morbidity].
    Revenok ND; Smorodintsev AA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():361-71. PubMed ID: 5860954
    [No Abstract]   [Full Text] [Related]  

  • 22. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of the use of a live measles vaccine prepared from the Leningrad-16 strain].
    Taros LIu; Boĭchuk LM; Smorodintsev AA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():57-77. PubMed ID: 5860963
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preliminary results of the study with a live measles vaccine from the Leningrad-4 strain].
    Kolesnikov LV; Khaletskaia EV; Gulianitskiĭ NA; Shestakova LS
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():385-7. PubMed ID: 5860956
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reactivity to live measles vaccine of the ESHCH strain of the Academy of Medical Sciences, RSFS].
    Tsipershteĭn MIa
    Pediatr Akus Ginekol; 1970; 4():25-6. PubMed ID: 5504822
    [No Abstract]   [Full Text] [Related]  

  • 27. [Specific prophylaxis in measles. I. Preparation of a vaccine with modified live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y
    Stud Cercet Inframicrobiol; 1966; 17(5):371-6. PubMed ID: 5964005
    [No Abstract]   [Full Text] [Related]  

  • 28. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
    Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
    Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination against measles with Biken measles virus vaccine. Combined use of killed and live vaccines.
    Lin ST; Huang CC; Lee PP; Yang CK; Hsu ST; Chiang TP
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1966; 7(3):133-40. PubMed ID: 5980579
    [No Abstract]   [Full Text] [Related]  

  • 32. [Data for the evaluation of the epidemiological effectiveness of a live measles vaccine prepared from the Leningrad-4 strain].
    Nikitin MIa; Kozlova NA; Kulikova VA; Malafeeva LK; Petrova TN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():309-20. PubMed ID: 5893106
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experience of a vaccination campaign using the Edmoston Zagreb strain (EZ 19) coinciding with reports about numerous cases of measles in the USL 23 region of Arezzo].
    Rossi PL; Poggini G; Bagianti C; Giglio E; Piergiovanni MG; Maruccia T; Pisano G
    Clin Ter; 1993 Apr; 142(4):335-40. PubMed ID: 8330476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Data for the study of reactogenic and epidemiological effectiveness of a live measles vaccine prepared from the Leningrad-16 strain].
    Nikitin MIa; Kozlova NA; Kulikova VA; Petrova TN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():321-9. PubMed ID: 5860951
    [No Abstract]   [Full Text] [Related]  

  • 35. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic.
    Baruzzi RG; Abdala N; Black FL
    Trop Geogr Med; 1982 Mar; 34(1):7-12. PubMed ID: 7080192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Single or double dose of vaccine needed for the eradication of measles in Spain?].
    Vitoria Miñana I; Morales Suárez-Varela M; Cotanda Gutiérrez P; Asensi Botet F
    An Esp Pediatr; 1993 Feb; 38(2):130-4. PubMed ID: 8439098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measles-rubella vaccination campaign].
    Infirm Fr; 1984 Jan; (251):23-6. PubMed ID: 6561159
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the epidemiological effectiveness in Kirghizia of a live measles vaccine prepared from the Leningrad-4 strain].
    Aminova MG; Cheredova NG; Novokreshchenova FA; Atakhanov KA; Aĭdaraliev KhA; Asankhodzhoev DD
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():335-45. PubMed ID: 4221934
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immuno-epidemiological effectiveness of Beckenham's measles vaccine].
    Topciu V; Arion R; Moldovan E; Olaru G; Csaky N; Băcilă E; Halasz C; Weitzen O; Dan G; Mîrza I; Magyorosi E; Jeremias N; Nicolau D; Yampan R
    Stud Cercet Virusol; 1972; 23(2):145-50. PubMed ID: 4646494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.